Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
4.265
-0.135 (-3.06%)
Streaming Delayed Price
Updated: 1:03 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
June 07, 2024
FDA approves Geron's Rytelo (imetelstat) for adults with low-to intermediate-1 risk myelodysplastic syndromes and transfusion-dependent anemia Geron's first commercial treatment targets a market...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 07, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 07, 2024
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!
Via
InvestorPlace
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
June 07, 2024
Via
Benzinga
Navigating 10 Analyst Ratings For Geron
April 29, 2024
Via
Benzinga
The Latest Analyst Ratings For Geron
April 10, 2024
Via
Benzinga
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
June 06, 2024
From
Geron Corporation
Via
Business Wire
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading
March 15, 2024
Via
Investor Brand Network
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2024
From
Geron Corporation
Via
Business Wire
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024
Via
Benzinga
Geron (GERN) Q1 2024 Earnings Call Transcript
May 03, 2024
GERN earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GERN Stock Earnings: Geron Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
GERN stock results show that Geron beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
May 02, 2024
From
Geron Corporation
Via
Business Wire
The Top 3 Penny Stocks to Buy in April 2024
May 02, 2024
Our economy is experiencing some decline, but it will rebound, use this opportunity to invest in these penny stocks to buy.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
April 26, 2024
Via
Benzinga
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
April 25, 2024
From
Geron Corporation
Via
Business Wire
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Geron Corporation
Via
Business Wire
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
April 12, 2024
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'
April 11, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO).
Via
Benzinga
Geron to Participate at Upcoming Investor Conferences in April
April 03, 2024
From
Geron Corporation
Via
Business Wire
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
March 20, 2024
Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel
Via
MarketBeat
Exposures
Product Safety
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
March 19, 2024
From
Geron Corporation
Via
Business Wire
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
March 18, 2024
Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International. Nuvei shares jumped 14.1% to...
Via
Benzinga
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 18, 2024
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday. Shares of Logitech International S.A. (NASDAQ: LOGI) fell in today’s pre-market...
Via
Benzinga
Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday?
March 15, 2024
Wall Street continues to maintain a risk-off sentiment in Friday’s session, echoing the pessimism triggered by Thursday’s unexpectedly high producer inflation figures.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Cancer Focused-Geron Stock On Friday?
March 15, 2024
Geron sees lower share price with high volume. FDA committee votes favorably on imetelstat for transfusion-dependent anemia in adult MDS patients. June 16, 2024, set as FDA target action date....
Via
Benzinga
Exposures
Product Safety
Why Is Geron (GERN) Stock Up 94% Today?
March 15, 2024
Geron stock is on the rise Friday with heavy trading of GERN shares after the company's blood disorder drug got new backing.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.